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I N T R O D U C T I O N
Exogenously applied arachidonic acid (AA) or stimu-
lation of certain Gq-coupled receptors (GqPCRs) en-
hances as well as inhibits N current (Barrett et al., 
2001; Liu et al., 2001; Liu and Rittenhouse, 2003a; and 
see Heneghan et al. in this issue). In Heneghan et al. 
(2009), we found that the form of modulation ob-
served depends on which accessory CaV subunit is co-
expressed with CaV2.2. When CaV1b, CaV3, or CaV4 
is present, AA (or receptor agonist) rapidly enhances 
N current; however, enhancement quickly progresses 
to robust inhibition. In contrast, currents from CaV2a-
containing channels exhibit sustained enhancement. 
Of the known CaV subunits, only CaV2a is palmi-
toylated on its two N-terminal cysteine residues (Chien 
et al., 1996; Takahashi et al., 2003). We hypothesized 
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that persistent enhancement may result from the pal-
mitoyl groups of CaV2a assuming a position within 
the membrane that prevents AA from interacting with 
the N channel’s inhibitory sites. In support of this pos-
sibility, we found that AA no longer enhanced but in-
stead inhibited N current from channels containing a 
depalmitoylated CaV2a (CaV2a(C3,4S); Chien et al., 
1996). Additionally, when CaV2a’s N terminus was 
substituted into CaV1b to form the chimera CaV2a/
1b (Chien et al., 1998), N current was no longer in-
hibited, but instead enhancement was observed, which 
is consistent with the palmitoyl groups preventing in-
hibition. Lastly, exogenously applied palmitic acid suc-
cessfully minimized the inhibition normally observed 
with CaV3. Collectively, these findings suggest that 
the  palmitoyl  groups  are  sufficient  for  preventing   
N-current inhibition by the slow pathway. This signal 
transduction cascade is initiated by GqPCRs that use 
PIP2 breakdown (Wu et al., 2002; Gamper et al., 2004), 
resulting in release of a free fatty acid, most likely AA 
Orientation of palmitoylated CaV2a relative to CaV2.2 is critical 
for slow pathway modulation of N-type Ca
2+ current by tachykinin 
receptor activation
Tora Mitra-Ganguli,
1,2 Iuliia Vitko,
3 Edward Perez-Reyes,
3,4 and Ann R. Rittenhouse
1,2
1Department of Physiology and 
2Program in Neuroscience, University of Massachusetts Medical School, Worcester, MA 01655
3Department of Pharmacology and 
4Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22908
The Gq-coupled tachykinin receptor (neurokinin-1 receptor [NK-1R]) modulates N-type Ca
2+ channel (CaV2.2 or 
N channel) activity at two distinct sites by a pathway involving a lipid metabolite, most likely arachidonic acid (AA). 
In another study published in this issue (Heneghan et al. 2009. J. Gen Physiol. doi:10.1085/jgp.200910203), we 
found that the form of modulation observed depends on which CaV is coexpressed with CaV2.2. When palmi-
toylated CaV2a is coexpressed, activation of NK-1Rs by substance P (SP) enhances N current. In contrast, when 
CaV3 is coexpressed, SP inhibits N current. However, exogenously applied palmitic acid minimizes this inhibition. 
These findings suggested that the palmitoyl groups of CaV2a may occupy an inhibitory site on CaV2.2 or prevent 
AA from interacting with that site, thereby minimizing inhibition. If so, changing the orientation of CaV2a relative 
to CaV2.2 may displace the palmitoyl groups and prevent them from antagonizing AA’s actions, thereby allowing 
inhibition even in the presence of CaV2a. In this study, we tested this hypothesis by deleting one (Bdel1) or two 
(Bdel2) amino acids proximal to the  interacting domain (AID) of CaV2.2’s I–II linker. CaVs bind tightly to the 
AID, whereas the rigid region proximal to the AID is thought to couple CaV’s movements to CaV2.2 gating. Al-
though Bdel1/2a currents exhibited more variable enhancement by SP, Bdel2/2a current enhancement was 
lost at all voltages. Instead, inhibition was observed that matched the profile of N-current inhibition from CaV2.2 
coexpressed with CaV3. Moreover, adding back exogenous palmitic acid minimized inhibition of Bdel2/2a cur-
rents, suggesting that when palmitoylated CaV2a is sufficiently displaced, endogenously released AA can bind to 
the inhibitory site. These findings support our previous hypothesis that CaV2a’s palmitoyl groups directly interact 
with an inhibitory site on CaV2.2 to block N-current inhibition by SP.
© 2009 Mitra-Ganguli et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi-
cation date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under 
a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported li-
cense, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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y386 CaV2a’s orientation controls N-channel modulation
binds to an inhibitory site on the channel. However, 
when CaV2a is present, its palmitoyl groups occupy the 
inhibitory  site  blocking  AA’s  interaction  with  CaV2.2 
(Fig. 1 B). For the palmitoyl groups of CaV2a to inter-
act with a specific site on CaV2.2, we predicted that 
CaV2a must reside in a specific orientation so that the 
palmitoyl groups situate close to or overlapping with 
the channel’s inhibitory site. To determine whether 
such an interaction might occur, in this study we tested 
whether changing CaV2a’s orientation relative to CaV2.2 
rescues inhibition.
All CaVs bind with high affinity to the cytoplasmic 
linker between domains I and II (Fig. 1 C) at the  inter-
acting domain (AID; Pragnell et al., 1994; Chen et al., 
2004; Opatowsky et al., 2004; Van Petegem et al., 2004). 
The region proximal to the AID appears to couple 
CaV’s movements to tune the gating properties of the 
channel, possibly by modulating the movements of IS6 
(Vitko et al., 2008; Zhang et al., 2008). This IS6-AID seg-
ment appears to form, in part, a rigid helical structure 
that regulates the orientation of CaV2a and conse-
quently its secondary interactions with CaV2.2. Deleting 
one (Bdel1) or two (Bdel2) amino acids in the IS6-AID 
segment (Fig. 1 D) changes the orientation of CaV2a to 
CaV2.2 (Fig. 1 E) with each shift in the helix (Vitko et al., 
2008). Therefore, we tested Bdel1 and Bdel2 mutants 
coexpressed with CaV2a for sensitivity to substance   
P (SP). Bdel1 exhibited minimal current enhancement, 
whereas Bdel2 rescued current inhibition by the slow 
pathway. In turn, exogenous palmitic acid reduced this 
inhibition. These findings are consistent with a model in 
which  the  orientation  of  a  palmitoylated  cytoplasmic 
protein, CaV2a, alters the regulation of the transmem-
brane protein, CaV2.2. This model raises the possibility 
that other cytosolic proteins may use their palmitoyl 
groups to interact with transmembrane segments of as-
sociated proteins to modify their behavior.
M AT E R I A L S   A N D   M E T H O D S
Site-directed mutagenesis
The  cDNA  encoding  the  rat  brain  CaV2.2  (GenBank/EMBL/
DDBJ accession no. AF055477) was subcloned into the plasmid vec-
tor pcDNA6 (Lin et al., 1997) and was provided by D. Lipscombe 
(Brown University, Providence, RI). To make the mutant Bdel1 
and  Bdel2  cDNAs,  a  1.5-kb  fragment  was  subcloned  into 
pCR2.1-TOPO (Invitrogen) and mutated using the QuikChange 
protocol and Pfu Ultra DNA polymerase (Agilent Technologies). 
Oligonucleotide primers, which were obtained from Invitrogen, 
were used without purification. All restriction enzymes were pur-
chased from New England Biolabs, Inc. The full-length cDNA   
was reassembled in the original plasmid vector that was cut with 
AscI and BsiWI by ligating the following fragments: AscI(32)–
BlpI(355), BlpI–SacI(1407), and SacI–BsiWI(2991). The Bdel1 
and Bdel2 amino acid deletions were contained in the BlpI–SacI 
fragment. The sequence of this fragment was verified for each 
mutant by automated sequencing at the University of Virginia 
Biomolecular Research Facility.
(Liu and Rittenhouse, 2003a; Liu et al., 2006; Heneghan 
et al., 2009).
From these findings, we proposed the following model 
to explain loss of inhibition in the presence of CaV2a: 
AA is released after GqPCR stimulation of phospholipid 
breakdown (Fig. 1 A). Once released, AA normally 
Figure 1.  CaV2.2 model system to be tested by NK-1R activation. 
(A) Flow chart representing the signaling cascade used by SP to 
modulate N current. (B) Schematic of model to be tested: N chan-
nels consist of the pore-forming CaV2.2, which is made up of four 
homologous domains (I–IV) also referred to as pseudosubunits, 
2-1,  and  a  CaV.  Palmitoylated  CaV2a  blocks  endogenously 
liberated free AA from binding to CaV2.2’s inhibitory sites after 
exposure of cells to SP. AA’s enhancement site remains available 
and is shown here in the outer regions of CaV2.2, although the ac-
tual location of this site remains uncharacterized. (C) Topological 
organization of CaV2.2 showing the six transmembrane segments 
and pore loop (P) of each pseudosubunit. An intracellular linker 
tethers each pseudosubunit to the subsequent one. CaV binds the 
AID region on the I–II linker at a site (delineated by the dotted 
box) that overlaps with a binding site for G. (D) The amino acid 
deletions in the region proximal to the AID result in Bdel1 and 
Bdel2 mutant channels. (E) Cross-sectional views from the inner 
pore region of wt CaV2.2 and the two mutant channels. Sequential 
amino acid deletions in the IS6-AID segment of Bdel1 and Bdel2 
are  predicted  to  reorient  CaV2a  such  that  the  two  palmitoyl 
groups (small white circles) are displaced from their wt positions.  Mitra-Ganguli et al. 387
plated onto poly-l-lysine–treated glass-bottom dishes (Fluorodish; 
World Precision Instruments). BiFC was visualized by cyan fluo-
rescence signals that were collected with IPLab software and a 
Sensicam QE (Cooke) mounted on a microscope (100× objective 
and 2 × 2 binning; IX61; Olympus) equipped with a confocal spin-
ning disk unit (Olympus). Digital images were background sub-
tracted using a region devoid of cells.
Pharmacology
SP was prepared as a 0.5-mM stock solution in 0.05 M acetic acid 
and stored at 20°C. To make a working concentration of 5 nM, 
the stock was serially diluted with bath solution daily. Palmitic acid 
was dissolved in 100% ethanol to make a stock solution. Working 
solutions were made by diluting the stock 1:1,000 with bath solu-
tion. BSA (fraction V, heat shock, fatty acid ultra free; Roche) was 
dissolved in the bath solution and diluted further to make a final 
concentration  of  1  mg/ml.  All  chemicals  were  obtained  from 
Sigma-Aldrich except where noted. Drugs were applied with a 
gravity-driven perfusion system, and complete bath exchange was 
achieved within 10–14 s.
Data analysis
After the onset of the test pulse, maximal inward current of whole-
cell traces was measured using a trough-seeking function. Percent 
change in current amplitude was measured as [(I  I’)/I] × 100, 
where I is the mean amplitude of peak current measured from 
five current traces before drug application and I’ is the mean cur-
rent amplitude measured from five current traces at least 2 min 
after application of SP, unless otherwise noted.
Statistical analysis
Summary data are presented as mean ± SEM. Mean current am-
plitude before and after application of SP was compared using a 
two-tailed paired t test. Two means were compared using a two-
way Student’s t test. Statistical significance was set at P < 0.05. Data 
were analyzed using Excel (Microsoft) and Origin (OriginLab).
Online supplemental material
Fig. S1 shows BiFC images of CaV2.2, Bdel1, and Bdel2 colocal-
izing with CaV2a to the plasma membrane. Online supplemen-
tal  material  is  available  at  http://www.jgp.org/cgi/content/ 
full/jgp.200910204/DC1.
R E S U LT S
SP enhances wt Cav2.2 current via a BAPTA-sensitive, 
voltage-independent pathway
We characterized several biophysical properties of N-
current enhancement by SP. In HEK-M1 cells transfected 
with CaV2.2, CaV2a, 2-1, and the NK-1R, we first tested 
whether as with inhibition, the enhancement of N current 
occurs  via  a  BAPTA-sensitive  pathway.  In  cells  dialyzed 
with a low (0.1 mM) BAPTA concentration, application of 
5 nM SP enhanced N current 62 ± 18% (Fig. 2, A [left] 
and B). In contrast, when cells were dialyzed with a high 
(20 mM) BAPTA concentration for at least 2 min to che-
late intracellular Ca
2+, SP no longer elicited current mod-
ulation (Fig. 2, A [right] and B). Thus, enhancement 
involves a BAPTA-sensitive pathway similar to that shown 
earlier for M1R-mediated N-current inhibition (Beech   
et al., 1991; Bernheim et al., 1991; Mathie et al., 1992; Liu 
et al., 2001; Liu and Rittenhouse, 2003a).
Transfection
Human embryonic kidney (HEK) cells with a stably transfected 
M1 receptor (M1R; HEK-M1) were grown at 37°C with 5% CO2 in 
Dulbecco’s modified Eagle’s medium/F12 supplemented with 
10% FBS, 1% G418, 0.1% gentamicin, and 1% HT supplement 
(Invitrogen). For transfection, cells were plated in 12-well plates 
at 50–80% confluency. Cells were transiently transfected using 
Lipofectamine PLUS reagent (Invitrogen) as per the manufac-
turer’s instructions. The transfection mixture consisted of plas-
mids encoding wild-type (wt) or mutant Cav2.2 e[
a10, ∆18a, 
24a, 31a, 37b, 46] (GenBank accession no. AF055477; Fig. 1, C 
and  D;  Vitko  et  al.,  2008),  2-1  (GenBank  accession  no. 
AF286488), and either CaV2a (GenBank accession no. M80545) 
or CaV3 (GenBank accession no. M88751) at a 1:1:1 molar ratio. 
28 ng/well of plasmid encoding neurokinin-1 receptor (NK-1R; 
GenBank accession no. AY462098; UMR cDNA Resource Cen-
ter, University of Missouri, Rolla, MO) and enhanced green fluo-
rescent protein cDNA (used at <10% of total cDNA) were also 
included in the transfection medium. Cells were plated on poly-
l-lysine–coated coverslips 24–72 h after transfection. However, 
currents elicited from Bdel1 and Bdel2 mutants were not detect-
able. To boost mutant channel expression by increasing tran-
scription, 80 ng of plasmid containing the SV40 T antigen was 
included during transfection. Currents were recorded between 
24 and 76 h after transfection.
Electrophysiology
Whole-cell Ba
2+ currents were recorded at room temperature 
(20–24°C) using a patch-clamp amplifier (model 3900a; Dagan 
Instruments Inc.). Currents were filtered at 1–5 kHz using the 
amplifier’s four-pole low-pass Bessel filter and digitized at 20 kHz 
with a micro1401 interface (Cambridge Electronic Design [CED]). 
Data were acquired and analyzed using either IPLab 4.0 (Scana-
lytics) as described previously (Vitko et al., 2007) or Signal 2.16 
(CED)  and  stored  on  a  personal  computer.  Before  analysis,   
capacitive and leak currents were subtracted using a scaled-up 
hyperpolarizing test pulse to 100 mV. For all recordings, cells 
were held at 90 mV and given either a 24- or 100-ms depolar-
ization to the test pulse indicated. Unless mentioned, the proto-
col was repeated every 4 s. For prepulse experiments, a 24-ms 
depolarization (P1) was followed 250 ms later by a step depolar-
ization to 120 mV for 25 ms, then followed 30 ms later by an-
other 24-ms depolarization (P2) and repeated every 10 s (Fig. 2 C). 
Electrodes were pulled from borosilicate glass capillary tubes. 
Each electrode was fire polished to 1 µm to yield pipettes with 
resistances of 2–3 MΩ. The external solution contained 125 mM 
NMG-aspartate, 10 mM HEPES, and 5 or 20 mM barium (Ba
2+) 
acetate; pH was adjusted to 7.5 with CsOH. When the Ba
2+ con-
centration was lowered from 20 to 5 mM (for recording wt Cav2.2 
currents),  135  mM  NMG-aspartate  was  substituted  for  Ba
2+.   
The internal solution of the pipette consisted of 135 mM Cs- 
aspartate, 10 mM HEPES, 0.1 mM 1,2-bis(O-aminophenoxy)   
ethane-N,N,N’,N’-tetraacetic acid (BAPTA), 5 mM MgCl2, 4 mM 
ATP, and 0.4 mM GTP; the pH was adjusted to 7.5 with CsOH. 
When 20 mM BAPTA was included in the pipette solution, the 
Cs-aspartate concentration was lowered accordingly in the inter-
nal solution.
Bimolecular fluorescence complementation (BiFC)
BiFC imaging was performed as previously described (Vitko et al., 
2008).  In  brief,  a  small  C-terminal  (amino  acids  159–238)  se-
quence of cyan fluorescent protein (CFP) was fused to the C ter-
minus  of  full-length  CaV2a  (Fig.  S1  A).  The  big  N-terminal 
fragment of CFP (amino acids 1–158) was fused to the N terminus 
of CaV2.2, Bdel1, or Bdel2. Plasmids encoding 250 ng CaV2.2, 
Bdel1, or Bdel2, 1 µg 2-1, and 1 µg of full-length 2a were tran-
siently transfected into HEK-293 cells. After 18 h, the cells were 388 CaV2a’s orientation controls N-channel modulation
Fig. 2 F, SP significantly decreased TTP (P < 0.05; n = 6) 
when CaV2a was coexpressed with CaV2.2 similar to   
native N current (Barrett et al., 2001). Collectively, these 
tests indicate that in addition to recapitulating the prop-
erties of native N-current enhancement, recombinant 
N-current enhancement exhibits similar properties to   
N-current  inhibition  by  SP:  sensitivity  to  the  internal 
BAPTA concentration but unaltered by prepulses.
Modulation of Bdel1 current by SP is disrupted
We next examined whether mutant CaV2.2 channels 
coexpressed with CaV2a exhibit similar modulation 
by SP. Bdel1 has a single amino acid deletion in the 
IS6-AID  segment  (Vitko  et  al.,  2008)  that  reorients 
CaV2a’s position relative to Bdel1 (Fig. 1, D and E). 
We  hypothesized  that  this  deletion  may  sufficiently 
move CaV2a such that the palmitoyl groups no longer 
occupy the putative inhibitory site so that SP will now 
inhibit rather than enhance current. Although SP en-
hanced Bdel1 currents in seven of seven cells (Fig. 3 A), 
enhancement varied from as little as 12% to as high as 
135% and thus was not significant (Fig. 3, B and C). To 
rule out the possibility that inhibition was disrupted as 
a result of a change in the inhibitory site, we tested 
Bdel1 coexpressed with CaV3 for modulation by SP. 
Second, we tested whether enhancement, as with in-
hibition, is insensitive to prepulse facilitation of current. 
Similar to our previous studies using exogenously ap-
plied AA (Barrett et al., 2001; Liu et al., 2001), M1R ago-
nist (Liu and Rittenhouse, 2003a), or SP activation of 
NK-1Rs (Heneghan et al., 2009), current enhancement 
occurred between 10 and 0 mV (Fig. 2, C–E). Current–
voltage (I-V) plots revealed that maximal enhancement 
occurred  10  mV  negative  to  the  voltage  that  elicited 
peak inward current—in this case at 0 mV (Fig. 2 E). Thus, 
we measured N current over time by stepping to a test 
potential 10 mV to the left of where maximal inward 
current occurs. Using this protocol, a slight relief from 
tonic inhibition was observed under control conditions; 
however, after SP application, both P1 and P2 currents 
exhibited similar significant (P < 0.05) enhancement 
(62 ± 18% and 50 ± 11%, respectively) compared with 
control currents (Fig. 2, C and D).
AA-induced enhancement of N current coincides with 
an increased rate of activation in SCG neurons (Barrett 
et al., 2001). Therefore, in a third study, we examined 
whether enhancement by SP involves an increase in acti-
vation kinetics, detected as a change in time to peak 
(TTP) inward current. We measured the TTP of N cur-
rent before and after application of SP. As shown in 
Figure  2.  NK-1R activation enhances Cav2.2/CaV2a 
currents.  HEK-M1  cells  were  transiently  transfected 
with  CaV2.2,  2-1,  2a,  and  NK-1R.  (A)  Individual 
traces taken before and 2 min after application of 5 nM 
SP. (left) 0.1 mM BAPTA was present in the internal so-
lution. (right) 20 mM BAPTA in the internal solution. 
(B)  Comparison  of  the  mean  percent  enhancement 
for cells dialyzed with 0.1 or 20 mM BAPTA (n = 4–9); 
*, P < 0.05 compared with inhibition in the presence 
of 0.1 mM BAPTA. (C) Individual traces taken before 
and 2 min after application of SP. P1 and P2 represent 
current measured before and after a prepulse, respec-
tively.  (D)  Summary  of  the  percent  enhancement   
by SP at 0 mV before and after a prepulse (n = 9); *,   
P < 0.05 compared with P1 and P2 control currents before 
SP application. (E) Averaged current–voltage relation-
ships measured before (closed circles) and after (open 
circles) application of SP. (F) Summary of TTP before 
and after application of SP (n = 6); *, P < 0.05 com-
pared with control. Error bars represent SEM. Bars,   
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observed with CaV2.2/2a channels, became more vari-
able with Bdel1/2a channels, whereas Bdel2/2a cur-
rents exhibited robust inhibition similar to CaV2.2/3 
current modulation (Fig. 4 E).
It is unlikely that differences in modulation are caused 
by the loss of CaV binding to Bdel1 because normally 
little to no current is observed when CaV is left out of 
the transfection (Vitko et al., 2008). We also found that 
when Bdel2 was cotransfected with only 2-1, mean 
current amplitude was 11 ± 7 pA (n = 3), indicating 
that to observe currents CaV must be bound to chan-
nels. Additionally, to confirm that differences in modu-
lation of Bdel mutants compared with wt Cav2.2 are not 
caused by the loss of CaV expression, we performed 
BiFC analysis (Kerppola, 2006; Vitko et al., 2008) using 
CaV2a coexpressed with CaV2.2, Bdel1, or Bdel2. This 
method utilizes CFP split into two nonfluorescent frag-
ments: one fragment is fused to CaV2.2’s N terminus, 
and the other fragment is fused to CaV2a’s C terminus 
(Fig. S1 A). Fluorescence occurs when the two halves of 
CFP reside close enough to each other to bind, forming 
an intact fluorescing CFP. We found that each channel 
produced a fluorescent signal at the plasma membrane 
(Fig. S1 B), indicating that the differences in modula-
tion were not caused by a loss of cell surface CaV2a ex-
pression. These results differ from our previous study 
with 3 core (Vitko et al., 2008) because the CFP frag-
ment was fused to a full-length 2a, which adds suffi-
cient flexibility to allow BiFC regardless of orientation.
Indeed, SP inhibited currents of Bdel1/CaV3 chan-
nels by 32 ± 10% (P < 0.05; Fig. 3, D and E). The mag-
nitude of inhibition did not differ significantly from   
wt CaV2.2/3 currents, indicating that the site of inhi-
bition remained unaffected by the amino acid deletion 
in the IS6-AID segment. Moreover, no facilitation of 
modulated currents was observed with Bdel1 whether 
expressed with CaV2a (Fig. 3, B and C) or CaV3 (Fig. 3, 
D and E).
SP inhibits Bdel2 currents in the presence  
of palmitoylated 2a
To determine whether an additional amino acid dele-
tion further alters N-current modulation, we tested the 
effects of SP on Bdel2 activity. We hypothesized that   
deletion of two amino acids (Fig. 1 D) might further 
displace CaV2a from its normal position (Fig. 1 E), re-
sulting in a more obvious disruption of N-current en-
hancement. After application of SP, robust inhibition of 
Bdel2 current was observed rather than enhancement 
(Fig. 4, A, B, and E). Inhibition was observed at all volt-
ages (Fig. 4 A) and was not relieved by a prepulse (P1, 
46 ± 7% vs. P2, 45 ± 8% at 10 mV). When inhibition of 
Bdel2/2a currents was compared with inhibition of 
CaV2.2/3 currents (Fig. 4, B and C), the magnitude of in-
hibition was similar and was not relieved by a prepulse 
(Fig. 4, D and E). Overall, current modulation by SP ex-
hibited unique properties with each change in the ori-
entation of CaV2a: enhancement of N current, normally 
Figure 3.  Modulation of Bdel1 current by SP is mod-
estly  disrupted.  HEK-M1  cells  were  transiently  trans-
fected with NK-1R, Bdel1, 2-1, 2a (A–C), or 3 (D 
and E). (A) Averaged current–voltage plots measured 
before and after application of SP (red). (B and C) In-
dividual sweeps elicited at 20 mV (B) and summary of 
enhancement (C) taken before and 2 min after appli-
cation of SP (red) before (P1) or after a prepulse (P2;   
n  =  7).  (D)  Representative  sweeps  taken  before  and   
2 min after application of SP. (E) Summary of the in-
hibition by SP at 20 mV caused by SP before (P1) and 
after a prepulse (P2; n = 4); *, P < 0.05 compared with 
control currents. Error bars represent SEM. Bars, 10 ms 
and 200 pA.390 CaV2a’s orientation controls N-channel modulation
and Bdel2/2a currents by SP occurs via a BAPTA-sensi-
tive pathway (Beech et al., 1991; Bernheim et al., 1991; 
Mathie et al., 1992). When the normally low (0.1 mM) 
BAPTA concentration was raised to 20 mM BAPTA,   
N-current inhibition by SP was no longer significant for 
CaV2.2/3 channels and was decreased with Bdel2/2a 
channels (Fig. 5, compare A with B; and Fig. 5 E). Sec-
ond, we tested whether BSA minimizes N-current inhi-
bition  by  SP.  Previously,  we  found  that  when  BSA  is 
included in the bath solution, inhibition of native and 
recombinant N current by M1R stimulation is lost (Liu 
and  Rittenhouse,  2003a;  Liu  et  al.,  2006;  Heneghan   
et al., 2009). Because BSA sequesters free AA released 
from phospholipids (Fig. 5 C) after receptor activation 
(Liu et al., 2006), decreased N-current inhibition is at-
tributed to decreased availability of free AA. When we 
tested both CaV2.2/3 and Bdel2/2a channels (Fig. 5, 
D and E) in the presence of BSA, N-current inhibition 
by SP was no longer observed.
Additionally, CaV2.2/3 current inhibition by SP was 
not relieved by a prepulse (Fig. 4, D and E), consistent 
with inhibition occurring via a voltage-independent path-
way (Kammermeier et al., 2000). Comparison of Bdel2/
2a and CaV2.2/3 current inhibition (Fig. 4, B–E and 
Fig. 5 E) shows that for both currents, inhibition involves 
a voltage-independent, BAPTA-sensitive pathway that ap-
pears to use a free fatty acid, most likely AA, as a signaling 
To determine whether the amino acid deletions affect 
tonic facilitation of control currents, we measured the 
prepulse  facilitation  ratio,  which  is  measured  by  the   
P2/P1 current amplitude ratio (Fig. 4, B–D). Although 
CaV2.2 currents showed small but significant prepulse 
facilitation (Fig. 4 D), both Bdel1 and Bdel2 currents 
decreased in amplitude after a prepulse. Interestingly, 
Bdel1 exhibited a significantly greater decrease in cur-
rent amplitude after a prepulse than did Bdel2, result-
ing in a significantly (P < 0.05) lower P2/P1 current 
ratio for Bdel1 than Bdel2 (Fig. 4 D).
Inhibition of Bdel2/2a currents by SP mimics inhibition  
of wt Cav2.2/3 currents
By deleting two amino acids in the IS6-AID segment,   
N-current modulation changes from enhancement to ro-
bust inhibition. If the palmitoyl groups of CaV2a were 
critical for toggling modulation but are now displaced 
to reveal AA’s inhibitory site on Bdel2, Bdel2/2a inhi-
bition  should  exhibit  properties  similar  to  Bdel2/3   
or CaV2.2/3. Because Bdel2/3 currents inactivate so 
rapidly, their peak current could not be compared with 
modulation of Bdel2/2a currents (Vitko et al., 2008). 
Therefore, we took a pharmacological approach to de-
termine whether the same slow pathway that inhibits 
CaV2.2/3 currents confers Bdel2/2a current inhibi-
tion. First, we tested whether inhibition of CaV2.2/3 
Figure 4.  NK-1R activation inhibits Bdel2 
currents.  HEK-M1  cells  were  transiently 
transfected  with  Bdel2,  2-1,  CaV2a, 
or  CaV3  and  NK-1R.  (A)  Averaged  cur-
rent–voltage plot measured before and af-
ter application of SP. (B and C) Individual 
traces from CaV2a-containing Bdel2 chan-
nels (B) or CaV3-containing wt channels   
(C) taken before and 2 min after applica-
tion of SP (red) before (P1) or after a pre-
pulse (P2). (D) Prepulse facilitation (ratio 
of P2/P1) for wt CaV2.2 (), Bdel1 (), 
and Bdel2 with either CaV2a () or CaV3 
();  *,  P  <  0.05  compared  with  Bdel1.   
(E) Summary of modulation of wt CaV2.2 
(),  Bdel1  (),  and  Bdel2  with  either 
CaV2a  ()  or  CaV3  ()  by  SP  before 
(closed) and after (open) a prepulse; *,   
P < 0.05 compared  with  control  currents   
(n = 4–9). Error bars represent SEM. Bars,   
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In our previous study, we found that coexpression of 
CaV2a with CaV2.2 and 2-1 results in enhancement of 
recombinant N current by M1R or NK-1R stimulation, 
whereas coexpression with CaV1b, CaV3, or CaV4 re-
sults in inhibition (Heneghan et al., 2009). In the pres-
ence of CaV2a, M1R activation enhances native and 
recombinant N but not L current (Liu and Rittenhouse, 
2003a; Liu et al., 2006; Heneghan et al., 2009; Roberts-
Crowley and Rittenhouse, 2009). Additionally, enhance-
ment of recombinant CaV2.2 and CaV2.3 currents by 
NK-1Rs has been described previously (Meza et al., 2007; 
Heneghan et al., 2009). Because these three channels 
show similar transmembrane organization (Catterall, 
2000),  the  differences  in  modulation  are  unlikely  to 
arise from nonspecific membrane effects that might al-
ter gating. Additional studies using free palmitic acid, 
depalmitoylated CaV2a, and chimeric CaVs indicated 
that CaV2a’s palmitoyl groups may confer the switch   
by blocking AA’s inhibitory actions to reveal latent en-
hancement (Heneghan et al., 2009). In this study, we 
molecule within the pathway. These findings are consis-
tent with Bdel2/2a current inhibition by SP occurring 
by a similar mechanism as CaV2.2/3 current inhibition 
by the slow pathway (Fig. 1 A; Heneghan et al., 2009).
Free palmitic acid blocks inhibition of Bdel2 currents
In our companion study, exogenously applied palmitic 
acid  blocked  inhibition  of  CaV2.2/3  currents  by  SP 
(Heneghan et al., 2009). If N-current inhibition of Bdel2/
2a and CaV2.2/3 channels involves a similar pathway, 
exogenously applied palmitic acid also should minimize 
inhibition  of  Bdel2/2a  currents  after  SP  application 
(Fig. 6 A). To test this hypothesis, cells expressing Bdel2 
and CaV2a were preincubated with 10 µM palmitic acid 
for at least 8 min before application of SP. In the contin-
ued presence of palmitic acid, SP inhibited N current by 
21 ± 4% (Fig. 6, C and D). This inhibition was significantly 
reduced (P < 0.05) by >50% compared with inhibition in 
the absence of palmitic acid (46 ± 7%; Fig. 6 D). These 
findings are consistent with a model in which the palmi-
toyl groups of CaV2a (Fig. 6 A) antagonize N-current in-
hibition by free AA that is released after SP application.
Figure 5.  Bdel2 current inhibition by SP is voltage 
independent, BAPTA sensitive, and antagonized by 
BSA similar to slow pathway modulation of CaV2.2. 
HEK-M1  cells  were  transiently  transfected  with   
NK-1R, either Bdel2 or wt CaV2.2, 2-1, and either 
CaV2a or CaV3. (A and B) Individual traces from 
wt CaV2.2/3 (left) and Bdel2/2a currents (right) 
taken before and 90 s after application of SP with 
0.1 mM BAPTA (A) or 20 mM BAPTA (B) in the 
pipette solution. (C) Schematic showing BSA’s site 
of action. (D) 1 mg/ml BSA in the external bath 
medium.  Left,  wt  CaV2.2/3;  right,  Bdel2/2a. 
(E)  Summary  of  the  percent  current  remaining   
after SP from CaV2.2/3 and Bdel2/2a channels;   
*, P < 0.05 compared with control currents (n = 6–9); 
†, P < 0.05 using a one-way paired t test compared 
with  unstimulated  current  amplitudes.  Error  bars 
represent SEM. Bars, 10 ms and 200 pA.392 CaV2a’s orientation controls N-channel modulation
logical profiles. Preincubation of SCG neurons with the 
AA scavenger BSA or with the PLA2 antagonist oleoy-
loxyethyl phosphorylcholine minimized enhancement 
and inhibition of native N current by M1R agonists (Liu 
and Rittenhouse, 2003a). CaV2.2 current modulation by 
manipulated the N-channel’s pore-forming subunit 
CaV2.2 to alter CaV2a’s orientation relative to CaV2.2. 
We hypothesized that one (Bdel1) or two (Bdel2) dele-
tions  in  the  rigid  IS6-AID  segment  would  displace 
CaV2a  sufficiently  from  its  normal  orientation  such 
that its palmitoyl groups no longer interact with the in-
hibitory site. Moreover, we predicted that with CaV2a 
reoriented, the N-current enhancement, normally ob-
served after SP application, would be masked by rescued 
inhibition.
We found that deleting a single amino acid in the IS6-
AID segment to form Bdel1 (Vitko et al., 2008) resulted 
in highly variable N-current enhancement of Bdel1/2a 
channels (Fig. 3). Deleting two amino acids in the IS6-AID 
segment to form Bdel2 resulted in robust N-current   
inhibition replacing enhancement by SP (Fig. 4). In 
turn, preincubation with 10 µM palmitic acid mini-
mized inhibition of Bdel2/2a currents (Fig. 6), as was 
observed with wt CaV2.2/3 currents (Heneghan et al., 
2009), suggesting that the palmitoyl groups of CaV2a 
no longer reside in their wt position. Current inhibition 
of both CaV2.2/3 and Bdel2/2a channels (Figs. 4–5) 
exhibited similar properties to native N-current inhibi-
tion by the slow pathway in sympathetic neurons (Liu 
and Rittenhouse, 2003a), suggesting that displacement 
of CaV2a rescued inhibition mediated by phospholipid 
breakdown. These findings support a model in which 
CaV2a’s palmitoyl groups may compete with and an-
tagonize AA binding to a site on CaV2.2 that confers   
N-current inhibition by the slow pathway.
CaV2.2/2a current enhancement and Bdel2/2a current 
inhibition both occur by a voltage-independent, BAPTA-
sensitive pathway
Several of our findings advance the notion that the 
GqPCRs NK-1R and M1R use the same slow pathway to 
mediate both enhancement and inhibition (Fig. 1 A). 
First, both enhancement and inhibition of CaV2.2 currents 
by SP require low concentrations of BAPTA (0.1 mM)   
to observe modulation; the presence of 20 mM BAPTA 
in the pipette solution minimized modulation (Figs. 2 
and 5). Native N-current inhibition by M1Rs in SCG 
neurons (Beech et al., 1991; Bernheim et al., 1991; 
Mathie et al., 1992; Shapiro and Hille, 1993; Liu and 
Rittenhouse, 2003b) and hippocampal pyramidal neu-
rons (Tai et al., 2006) and CaV2.3 current inhibition by 
NK-1Rs (Meza et al., 2007) are also BAPTA sensitive. 
Second, unlike membrane-delimited inhibition (De Waard 
et al., 2005), a prepulse preceding the test pulse has no 
effect on the magnitude of N-current enhancement 
(Fig. 2 B) or inhibition (Fig. 4 E) by SP. Both NK-1Rs 
and M1Rs inhibit native N current via a voltage-indepen-
dent pathway in SCG neurons (Beech et al., 1991; Mathie 
et  al.,  1992;  Shapiro  and  Hille,  1993;  Kammermeier   
et al., 2000; Liu and Rittenhouse, 2003b). Third, en-
hancement and inhibition exhibit similar pharmaco-
Figure 6.  Exogenously applied palmitic acid blocks Bdel2 cur-
rent inhibition by SP. HEK-M1 cells were transiently transfected 
with Bdel2, 2-1, CaV2a, and NK-1R. (A) Schematic represent-
ing preincubation of cells with 10 µM palmitic acid blocks free 
AA, released after stimulation of NK-1R, from occupying the in-
hibitory site. Enhancement site, not depicted. The two exogenous 
palmitic acids (magenta) are shown bound to the inner region   
of Bdel2, antagonizing AA from binding to the inhibitory sites. 
(B and C) Individual traces taken before and 2 min after applica-
tion of 5 nM SP alone (B) or in the presence of 10 µM palmitic 
acid (C). (D) Summary of Bdel2 inhibition by SP in the presence 
of 10 µM palmitic acid (PA). *, P < 0.05 compared with current 
amplitude before SP (n = 7) or compared with the presence of 
palmitic acid alone (n = 6). **, P < 0.05; percent inhibition by 
SP compared with percent inhibition by palmitic acid + SP. Error 
bars represent SEM. Bars, 10 ms and 200 pA.  Mitra-Ganguli et al. 393
of current is detected with CaV2.2 (Cantí et al., 2001; 
Leroy et al., 2005), Bdel1 (Vitko et al., 2008), or Bdel2 
(this study) even when T antigen is included. These ob-
servations, along with studies of other calcium channels 
(Singer et al., 1991; Wakamori et al., 1993), support the 
notion that to observe a robust current, a  subunit 
must  be  associated  with  the  channel  in  mammalian 
cells. Our BiFC imaging data (Fig. S1) document that 
CaV2a binds to Bdel1 and Bdel2 at the plasma mem-
brane. Because association of the two complementary 
parts of cerulean stabilizes the complex, the data can-
not tell us whether CaV2a dissociates. However, in pre-
vious studies in which dissociation of  subunits was 
documented, reassociation was also detected (Hidalgo 
et al., 2006; Hidalgo and Neely, 2007), suggesting that if 
CaV2a can bind to CaV2.2, it will bind. Additional BiFC 
measurements of Bdel1 and Bdel2 coexpressed with a 
CaV core protein containing a truncated C terminus 
indicate that the  subunit is displaced relative to the 
pore in positions distinct from wt and from one another 
(Vitko et al., 2008).
Displacement of CaV2a from its normal orientation  
to CaV2.2 converts N-current enhancement to inhibition
The putative displacement of the palmitoyl groups may 
disrupt N-channel modulation by the slow pathway. 
With a single amino acid deletion in Bdel1, N current 
no longer exhibited significant enhancement by SP as a 
result of the increased variability of modulation. In con-
trast, when Bdel1 was coexpressed with CaV3, SP signif-
icantly  inhibited  current,  indicating  that  the  inhibitory   
site on the 1 subunit remains functional. This latter 
finding rules out the possibility that disrupted gating 
underlies the increased variability in enhancement be-
cause Bdel1/CaV3 channels also exhibit disrupted gat-
ing (Vitko et al., 2008) yet are inhibited by SP. Moreover, 
this finding indicates that the low-affinity interactions 
between CaV3 and Bdel1 play at most a minor role in 
slow pathway inhibition of N current (He et al., 2007). 
Although the increased variability of Bdel1 current en-
hancement  appears  independent  of  altered  protein–
protein interactions, it is possible that the switch from 
current enhancement to inhibition for Bdel2 occurs as 
a result of changes in low-affinity interactions between 
CaV2a  and  Bdel2  arising  from  deletions  in  the  I–II 
linker. However, we ruled out this possibility because   
exogenously applied palmitic acid significantly reduced 
current inhibition despite the novel orientation of CaV2a 
to Bdel2 (Fig. 6). Using a similar experimental design, 
we previously showed that exogenous application of pal-
mitic acid blocked SP-mediated inhibition of CaV2.2/3 
currents (Heneghan et al., 2009). It is also unlikely that 
toggling from enhancement to inhibition occurs as a 
result of altered membrane curvature because the bulk 
concentration of phospholipids and fatty acids near the 
channel would not be expected to change despite the 
NK-1Rs  exhibits  these  same  two  properties,  whereas 
BSA (Fig. 5, D and E) and oleoyloxyethyl phosphoryl-
choline  (not  depicted)  minimize  both  enhancement 
and inhibition. These findings suggest that although 
enhancement and inhibition may occur at distinct sites 
on N channels, they may be different manifestations of 
the  same  or  overlapping  signaling  pathways.  Thus, 
whether  SP  inhibits  or  enhances  N  current  is  deter-
mined by which CaV is coexpressed with CaV2.2 rather 
than from differences in signaling.
Further support for this idea comes from our finding 
that  Bdel2/2a  channels  exhibited  N-current  inhibi-
tion by SP similar to CaV2.2/3 channels. Therefore, we 
attempted to determine whether this inhibition also was 
caused by the slow pathway. Coexpression of CaV2a, 
compared with other CaVs, results in increased pre-
pulse-induced relief of tonic N-current inhibition and 
will undergo increased voltage-dependent, membrane-
delimited inhibition by pertussis toxin–sensitive G pro-
teins after stimulation of certain GPCRs (Cantí et al., 
2000; Feng et al., 2001). Released G is thought to 
bind to the CaV2.2’s I–II linker, disrupting the associa-
tion between the channel and CaV (Hümmer et al., 
2003; De Waard et al., 2005). However, the inhibited 
Bdel2/2a  currents  did  not  show  voltage-dependent   
relief from inhibition after a prepulse in low BAPTA 
conditions (Fig. 4). Additionally, inhibition was decreased 
or lost when cells were either dialyzed with 20 mM 
BAPTA or when BSA was included in the bath solution, 
respectively. These characteristics of inhibition match 
slow pathway inhibition of N current observed in SCG 
neurons (Mathie et al., 1992; Shapiro and Hille, 1993; 
Liu and Rittenhouse, 2003a). The overlapping biophys-
ical and pharmacological profile of modulation indi-
cates that the same signaling pathway mediates N-current 
enhancement of CaV2.2/2a channels and inhibition of 
CaV2.2/3 and Bdel2/2a channels. Moreover, the ob-
served enhancement of CaV2.2/2a versus inhibition of 
Bdel2/2a channels suggests that changes in orienta-
tion of CaV2a underlie the switch in modulation. How-
ever, it was possible that CaV2a did not stay bound to 
Bdel2  and  therefore  was  no  longer  present  to  block 
inhibition.
Bdel1 and Bdel2 alter CaV2a’s position relative to the  
1 subunit
Therefore, critical to understanding how the mutations 
in the IS6-AID segment disrupt enhancement was deter-
mining  whether  CaV2a  remained  associated  with 
mutated N channels because  subunits appear able   
to dissociate from channels in the plasma membrane 
(Hidalgo et al., 2006; Hidalgo and Neely, 2007). Several 
pieces of data indicate that although Bdel1 and Bdel2 
have a disrupted IS6-AID segment, CaV subunits con-
tinue to bind to CaV2.2. When  subunits are left out of 
the transfection protocol, <10% of the normal amount 394 CaV2a’s orientation controls N-channel modulation
transmission of nociceptive stimuli. Whether up- or 
down-regulation of the different Cavs can occur in 
response to a nociceptive stimulus remains untested; 
however, both increases and decreases in Ca
2+ currents 
have been observed in different neuronal subtypes after 
nerve injury (for review see McGivern and McDonough, 
2004). Thus, any disruption in modulation of N current 
by SP (for example, during transmission of nociceptive 
stimulation) may alter the frequency of action potential 
firing in the spinal cord that conveys nociceptive infor-
mation to the brain for further processing.
In summary, the data presented here, together with 
the findings of Heneghan et al. (2009), uncover a new 
function for protein palmitoylation. In addition to con-
ferring unique gating properties, CaV2a’s palmitoyl 
groups appear responsible for blocking inhibition to re-
veal enhancement by the slow pathway. In order for all 
of  these  processes  to  proceed  normally,  the  palmi-
toylated CaV2a must be in a specific orientation. The 
precise docking of the palmitoyl groups allows CaV2a 
to effectively reach up into the membrane with its fatty 
acid  “fingers” to  alter CaV2.2’s gating  properties and 
modulation. This new idea of a lipid modification of a 
cytosolic protein (CaV2a) interacting with a transmem-
brane protein (CaV2.2) to change its regulation extends 
the role of palmitoylation beyond its known functions 
of  targeting  or  tethering  proteins  to  the  membrane 
(Resh, 2006). Recently, Xue et al. (2004) made the novel 
observation that palmitoylation of a membrane-asso-
ciated form of retinal epithelial protein 65 (RPE65) not 
only  enhanced  its  targeting  to  membranes  but  most   
importantly enhanced its selectivity for binding to all-
trans-retinyl-esters. However, these findings could be 
explained by a simple tethering mechanism for palmi-
toylation. Lastly, our findings predict that palmitoylation 
may confer to other cytoplasmic proteins the potential 
to interact with particular transmembrane proteins to 
alter their function.
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